Thrombotic thrombocytopenic purpura
Thrombotic thrombocytopenic purpura is also known as thrombotic microangiopathic hemolytic anemia, platelet thrombosis syndrome, etc. It is an uncommon thrombotic microangiopathy, accompanied by microangiopathic hemolytic anemia. The clinical features are fever, thrombocytopenic purpura, microangiopathic lytic anemia, multiple nervous system injuries and renal damage. The cause is unknown, and it may be related to vascular factors, infection, and drug allergy. Most patients are between 10 and 40 years old, and about 60% are women. The onset is acute and the condition is serious. 2/3 of the cases die within 3 months. A few cases are slower, and the course of the disease can be several months to several years.
-
Site of disease:
Blood vessels skin -
Infectious :
Not contagious -
Frequent population:
There are slightly more females, but the peak age of onset is... -
Related symptoms:
Stomach ache shortened platelet lifespan thrombocytopenia fatigue bleeding tendency -
Concurrent disease:
Related Drugs
Dipyridamole
Indication: This product was once a commonly used drug for the treatment of coronary heart disease, but is now rarely used to prevent myocardial ischemia. Its antiplatelet aggregation effect can be used in heart surgery or valve replacement surgery to reduce the formation of thromboembolism.
Manufacturer:
Shanxi Shuangyan Pharmaceutical Co., Ltd.
Related Ingredients